Poland· PL-100285070
Inlyta
A axitinib product containing axitinibum, registered in Poland by Pfizer Europe MA EEIG. The same ATC class is registered in 14 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Axitinib is registered in 14 of 19 countries.
Countries holding a registration under ATC L01EK01 (axitinib), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Axitinib · ATC L01EK01
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of axitinib costs, country by country.
Normalised to the WHO defined daily dose (10 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Axitinib · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$89.71
The record
At a glance
URPL (Poland)- Active substance
- Axitinibum
- Manufacturer
- Pfizer Europe MA EEIG
- Country
- Poland (PL)
- ATC code
- L01EK01
- ATC class
- Axitinib
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909991004422
- gtin05909991004439
- gtin05909991004446
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
205 interactions on record for axitinib.
Graded by severity as the source publishes them — 64 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Axitinib · interactions on record
205 records
- 64 severe
- 117 moderate
- 24 minor
Most severe, free to view
- LonafarnibA16AX20severe
- BosentanC02KX01severe
- ConivaptanC03XA02severe
- MipomersenC10AX11severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Axitinib in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsAxitinib Accord 1 mg filmomhulde tablettenAccord Healthcare S.L.U.
- CzechiaAXITINIB ACCORDAccord Healthcare S.L.U., Barcelona
- FranceAXITINIB ACCORD 1 mg, comprimé pelliculéACCORD HEALTHCARE (ESPAGNE)
- SwitzerlandAxitinib Sandoz
- FinlandAxitinib AccordAccord Healthcare S.L.U.
- SwedenAxitinib Accord 1 mg Filmdragerad tablettAccord Healthcare S.L.U.
- IcelandAxitinib AccordAccord Healthcare S.L.U.
- SpainAXITINIB ACCORD 1 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Axitinib, Axitinib Sandoz
- Belgium · Axitinib Eg, Axitinib Eg (Eurogenerics)
- Bulgaria · Axitinib Sandoz, Акситиниб Тева
- Cyprus · Axitinib Sandoz, Axitinib Stada
- Germany · Axitinib Al, Axitinib Hexal
- Denmark · Axitinib Stada, Axitinib Teva
- Estonia · Axitinib Sandoz, Axitinib Stada
- Spain · Axitinib Stada, Axitinib Teva
- Finland · Axitinib Avansor, Axitinib Sandoz
- France · Axitiinib Eg, Axitinib Biogaran
- United Kingdom (Northern Ireland) · Axitinib Genus Pharmaceuticals, Axitinib Teva Uk
- Greece · Axitinib Faran, Axitinib Sandoz
- Croatia · Aksitinib Alpha-Medical, Aksitinib Teva
- Hungary · Axitinib Onkogen, Axitinib Sandoz
- Iceland · Axitinib Accord, Axitinib Stada
- Italy · Axitinib Eg, Axitinib Sandoz
- Liechtenstein · Axitinib Accord, Inlyta
- Lithuania · Axitinib Sandoz, Axitinib Stada
- Luxembourg · Axitinib Eg, Axitinib Synthon
- Latvia · Axitinib Sandoz, Axitinib Stada
- Malta · Axitinib Synthon
- Netherlands · Axitinib Sandoz, Axitinib Stada
- Norway · Axitinib Accord, Axitinib Sandoz
- Portugal · Axitinib Teva
- Romania · Axitinib Stada
- Sweden · Axitinib Avansor, Axitinib Sandoz
- Slovenia · Aksitinib Sandoz, Aksitinib Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/de004b5e-0843-4f92-bc8d-8330db8871bd GET /v1/drugs/de004b5e-0843-4f92-bc8d-8330db8871bd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "1 mg",
"packaging": "05909991004422 ¦ Rpz ¦ EU/1/12/777/001 ¦ 78968\n28 tabl.\n05909991004439 ¦ Rpz ¦ EU/1/12/777/002 ¦ 78969\n56 tabl.\n05909991004446 ¦ Rpz ¦ EU/1/12/777/003 ¦ 78970\n180 tabl.",
"substance": "Axitinibum 1 mg",
"common_name": "Axitinibum",
"pl_product_id": "100285070",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about axitinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.